HYBRID EVENT: You Can Participate In Person At Sydney, Australia Or Virtually From Your Home Or Work
ICPRC · Registering as Listener

International Conference on Pediatric Rheumatology and Care

9–10 Nov 2026 Sydney, Australia Standard / Physical Participation
Listener Registration
$135
virtual · $195 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.
All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.
Apply

1. Policy on Cancellations & Refunds :

  • A full refund is possible only if the cancellation request is submitted at least 70 days before the conference, with formal paperwork completed at least 60 days prior.
  • If cancellation occurs between 60 and 30 days before the event, partial refunds may be granted based on administrative costs incurred.
  • Cancellations made within 30 days of the event are non-refundable, though participants will receive a credit valid for one year.
  • Registrations made less than 30 days before the event are not eligible for refunds, but may be transferred to another ISIT conference.
  • Since this conference is hybrid format, the organizer reserves the right to conduct the event either in-person or virtually. Please note that no refunds will be issued due to changes in the event format.
  • Virtual registration fees are non-refundable. A credit will instead be issued for use at a future conference event.

2. Participation & Registration Requirements :

  • To attend an ISIT event, participants must complete the registration process within the stipulated time.
  • The event schedule, venue, and format are subject to changes at the discretion of the organizers, with prior notice sent via email.
  • ISIT is not liable for any financial losses resulting from changes in event details.
  • Fees paid for registration are strictly non-refundable.
  • If the primary author cannot participate, a co-author may attend instead, but refunds will not be granted for non-attendance.

3. Submission & Publication Norms :

  • Researchers submitting papers to ISIT must ensure their institution or supervisor is aware of their submission.
  • Each submission is subject to a rigorous peer review before being accepted for presentation.
  • Only papers linked to a completed registration will be included in conference proceedings.
  • The submitting author is considered the primary author; ISIT does not verify individual authorship claims.
  • If any concerns regarding authorship arise and are validated, the paper will be withdrawn without reconsideration.
  • Once a paper is removed, it cannot be reintroduced into any ISIT publication.

4. Travel & Accommodation Responsibilities :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.

5. Visa & Invitation Letter Policy :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.
  • ISIT does not engage directly with consulates or embassies on behalf of attendees.
  • Participants must handle their own visa applications and processes.
  • Important Information Regarding Invitation Letters:
    • The invitation letter is provided solely for conference attendance and does not serve as a document for immigration, employment, or residency purposes.
    • The letter assists in visa applications but does not guarantee visa approval.
    • ISIT holds no responsibility for visa denials or processing delays, and all related costs are borne by the applicant.
    • Any alterations or unauthorized use of the invitation letter will result in its invalidation and possible cancellation of conference participation.
    • Legal action may be pursued if the document is misused.
    • By accepting the invitation letter, attendees agree to comply with international travel regulations and ethical participation standards.

6. Registration Transfers :

  • Registrations may be transferred to another individual from the same institution if the original participant cannot attend.
  • Transfer requests must be made via email to [email protected] with necessary details and supporting documents.
  • Transfers must be requested at least 14 days before the event; otherwise, they will not be accommodated.
  • Transferred registrations are not eligible for refunds.

7. General Considerations :

  • Any modifications or cancellations must be communicated in writing to [email protected].
  • Registration confirms acknowledgment and acceptance of these policies.
  • ISIT does not initiate automatic transactions; all payments are voluntarily completed by registrants.
  • Once registered, participants must submit a conference registration form within three days for confirmation.
  • Travel plans should only be finalized after receiving the official conference itinerary, which will be shared 15 days before the event.

8. Conference Programme and Participation Policy :

  • Presentations from different but relevant academic areas may be combined by the Organiser within an interdisciplinary or multidisciplinary programme to encourage cross-disciplinary understanding, interaction, and future research partnerships.
Payments encrypted & processed securely. Refundable up to 14 days before the event.

What you'll hear about

Session tracks covered across the event.
View all 11 tracks →
This track focuses on the latest advancements in the diagnosis and treatment of pediatric rheumatic diseases. Participants will explore novel therapeutic strategies and their implications for clinical practice.
This session will delve into the immunological mechanisms underlying pediatric rheumatic conditions. Researchers will present findings that enhance our understanding of disease pathogenesis and potential therapeutic targets.
This track examines effective clinical care models tailored for children with rheumatic diseases. Discussions will include multidisciplinary approaches and the integration of family-centered care.
This session highlights the role of molecular diagnostics in the early detection and management of pediatric rheumatic diseases. Experts will share insights on biomarkers and genetic testing applications.
This track focuses on bridging laboratory research with clinical applications in pediatric rheumatology. Presentations will cover recent translational studies that aim to improve patient outcomes.
This session addresses the importance of effective patient monitoring in managing pediatric rheumatic diseases. Strategies for optimizing disease management through technology and patient engagement will be discussed.
This track will explore cutting-edge laboratory techniques utilized in rheumatology research. Participants will gain insights into methodologies that enhance the understanding of disease mechanisms.
This session will focus on the development and implementation of therapeutic strategies for chronic pediatric rheumatic conditions. Discussions will include pharmacological and non-pharmacological interventions.
This track examines the psychosocial challenges faced by children with rheumatic diseases and their families. Experts will discuss interventions that support mental health and well-being.
This session will provide a platform for sharing global experiences and practices in pediatric rheumatology. Participants will discuss disparities in care and strategies for improving access to treatment worldwide.
This track will explore emerging trends and future directions in pediatric rheumatology research. Participants will engage in discussions about potential breakthroughs and their implications for clinical practice.